Marcie A. Goldstein

Davis Polk advised the underwriters in connection with the $230 million initial public offering of 23,000,000 units of Natural Order Acquisition Corp., which includes 3,000,000 units…

Davis Polk advised the representatives of the underwriters in connection with the $345 million initial public offering of 14,375,000 shares of common stock of Atea Pharmaceuticals, Inc.,…

Davis Polk advised the representatives of the underwriters in connection with the $402.5 million initial public offering of 28,750,000 shares of common stock by Allegro MicroSystems,…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…

Davis Polk advised the joint book runners in connection with the initial public offering of 57,500,000 units of Bluescape Opportunities Acquisition Corp. for aggregate proceeds of $575…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $175.8 million initial public offering of 10,637,500 shares of Class A…

Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised the sole book runner in connection with the initial public offering of 12,500,000 units of Yellowstone Acquisition Company for aggregate proceeds of $125 million…

Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of Decarbonization Plus Acquisition Corporation. Each unit consists…

Davis Polk advised  the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…